Drug:
Reaction: MYELOSUPPRESSION
20250101 - 20251231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 25096439 |
CN |
61 | 2 |
Myelosuppression, |
||||
| 302 | 25096585 |
CN |
51 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 303 | 25096635 |
CN |
62 | |
Myelosuppression, |
||||
FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, |
||||
| 304 | 25096862 |
CN |
50 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 305 | 25097104 |
CN |
43 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 306 | 25097113 |
CN |
64 | 1 |
Myelosuppression, Asthenia, Pyrexia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 307 | 25097121 |
CN |
70 | |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, IRON DEXTRAN, IRON DEXTRAN, |
||||
| 308 | 25097195 |
CN |
63 | |
Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, CARBOPLATIN, CARBOPLATIN, |
||||
| 309 | 25086736 |
CN |
79 | 1 |
Myelosuppression, |
||||
LENALIDOMIDE, |
||||
| 310 | 25087268 |
CN |
61 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 311 | 25087272 |
CN |
50 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 312 | 25087300 |
CN |
61 | 2 |
Myelosuppression, Haemorrhage subcutaneous, Gingival bleeding, |
||||
BEVACIZUMAB, CAPECITABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 313 | 25087304 |
RO |
||
Metastases to liver, Dermatitis acneiform, Polyneuropathy, Myelosuppression, Skin fissures, Paronychia, Stomatitis, |
||||
BEVACIZUMAB, BEVACIZUMAB, PANITUMUMAB, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, FLUOROURACIL, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, IRINOTECAN HYDROCHLORIDE, |
||||
| 314 | 25087579 |
CN |
74 | |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 315 | 25087766 |
CN |
54 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Haemoglobin decreased, |
||||
VENETOCLAX, |
||||
| 316 | 25087881 |
CN |
||
Multiple organ dysfunction syndrome, Myelosuppression, Sepsis, Bacillus infection, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 317 | 25088487 |
JP |
1 | |
Myelosuppression, Platelet count decreased, Rash, Erythema, |
||||
AMIVANTAMAB, |
||||
| 318 | 25088588 |
CN |
73 | |
Myelosuppression, |
||||
OLAPARIB, |
||||
| 319 | 25088982 |
CN |
49 | 2 |
Myelosuppression, Pneumonia, Thrombocytopenia, Granulocytosis, Vomiting, Coronavirus infection, Pleural thickening, Full blood count decreased, Light chain analysis decreased, Arteriosclerosis, Pharyngeal disorder, General physical health deterioration, |
||||
CARFILZOMIB, CARFILZOMIB, |
||||
| 320 | 25089013 |
CN |
59 | 1 |
Myelosuppression, Pyrexia, Gingival bleeding, |
||||
CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 321 | 25089640 |
CN |
9 | 2 |
Myelosuppression, Off label use, |
||||
PACLITAXEL, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 322 | 25089656 |
JP |
8 | 1 |
Myelosuppression, Platelet count decreased, Neutrophil count decreased, |
||||
PEMBROLIZUMAB, LENVATINIB, LENVATINIB, |
||||
| 323 | 25089658 |
CN |
73 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, |
||||
| 324 | 25089838 |
CN |
67 | |
Myelosuppression, |
||||
DURVALUMAB, GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 325 | 25089887 |
CN |
53 | |
Myelosuppression, Pruritus, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 326 | 25089910 |
CN |
52 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 327 | 25090100 |
CN |
41 | 1 |
Myelosuppression, Product use in unapproved indication, Chronic gastritis, Gastritis erosive, Therapy partial responder, |
||||
PEMBROLIZUMAB, TRASTUZUMAB, TRASTUZUMAB, OXALIPLATIN, CAPECITABINE, |
||||
| 328 | 25090371 |
CN |
62 | 1 |
Myelosuppression, |
||||
ERIBULIN MESYLATE, |
||||
| 329 | 25090511 |
CN |
||
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 330 | 25090758 |
16 | ||
Myelosuppression, |
||||
RUXOLITINIB, |
||||
| 331 | 25090908 |
CN |
51 | 2 |
Myelosuppression, Product use in unapproved indication, |
||||
FRUQUINTINIB, PACLITAXEL, PACLITAXEL, CISPLATIN, |
||||
| 332 | 25091207 |
JP |
1 | |
Myelosuppression, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 333 | 25091222 |
CN |
47 | 2 |
Agranulocytosis, Myelosuppression, |
||||
ABEMACICLIB, ABEMACICLIB, FULVESTRANT, DENOSUMAB, |
||||
| 334 | 25091967 |
CN |
65 | |
Myelosuppression, |
||||
| 335 | 25091985 |
CN |
62 | |
Myelosuppression, Infection, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 336 | 25092001 |
CN |
70 | |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 337 | 25092021 |
CN |
55 | 1 |
Myelosuppression, Platelet count decreased, Mouth ulceration, Neutrophil count decreased, Anaemia, White blood cell count decreased, |
||||
VENETOCLAX, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, CYTARABINE, |
||||
| 338 | 25092028 |
CN |
72 | 2 |
Myelosuppression, |
||||
VENETOCLAX, DECITABINE, |
||||
| 339 | 25082070 |
CN |
58 | 1 |
Myelosuppression, Off label use, |
||||
GEMCITABINE HYDROCHLORIDE, PACLITAXEL, |
||||
| 340 | 25082339 |
CN |
55 | |
Myelosuppression, Hydronephrosis, |
||||
FLUOROURACIL, |
||||
| 341 | 25082753 |
CN |
56 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
| 342 | 25082801 |
CN |
63 | 1 |
Myelosuppression, Product use in unapproved indication, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 343 | 25083055 |
CN |
54 | 2 |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 344 | 25083063 |
CN |
1 | |
Myelosuppression, |
||||
| 345 | 25083138 |
CN |
74 | |
Myelosuppression, |
||||
DURVALUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 346 | 25083243 |
CN |
57 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 347 | 25084083 |
CN |
59 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, TRASTUZUMAB, |
||||
| 348 | 25084343 |
CN |
||
Temperature intolerance, Pyrexia, Anaemia, Platelet count decreased, Myelosuppression, |
||||
| 349 | 25084515 |
CN |
||
Myelosuppression, |
||||
ETOPOSIDE, CARBOPLATIN, |
||||
| 350 | 25084606 |
CN |
58 | 2 |
Myelosuppression, Pseudomonal sepsis, Myelosuppression, Pseudomonal sepsis, |
||||
GILTERITINIB, GILTERITINIB, GILTERITINIB, AZACITIDINE, AZACITIDINE, AZACITIDINE, AZACITIDINE, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 351 | 25085209 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 352 | 25085211 |
CN |
||
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 353 | 25085553 |
CN |
||
Myelosuppression, Hepatic function abnormal, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 354 | 25085644 |
CN |
68 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL, FLUOROURACIL, |
||||
| 355 | 25085672 |
CN |
63 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 356 | 25085916 |
CN |
55 | 2 |
Myelosuppression, Aspergillus infection, |
||||
BENDAMUSTINE HCL, RITUXIMAB, ETANERCEPT, METHYLPREDNISOLONE, |
||||
| 357 | 25086502 |
CN |
58 | 1 |
Herpes zoster, Myelosuppression, Immunodeficiency, Off label use, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, FLUOROURACIL, FLUOROURACIL, DEXAMETHASONE SODIUM PHOSPHATE, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE, |
||||
| 358 | 25086556 |
CN |
74 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 359 | 25089492 |
78 | 1 | |
Anaemia, Leukopenia, Myelosuppression, Thrombocytopenia, Cirrhosis alcoholic, Oropharyngeal pain, Rhinorrhoea, |
||||
LINEZOLID, |
||||
| 360 | 25081652 |
CN |
63 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 361 | 25080534 |
CN |
66 | 2 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
| 362 | 25080728 |
CN |
57 | 2 |
Myelosuppression, Hyperbilirubinaemia, Leukopenia, Lymphopenia, Hypertension, |
||||
CARFILZOMIB, |
||||
| 363 | 25080863 |
CN |
72 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 364 | 25080872 |
CN |
52 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 365 | 25080873 |
CN |
48 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PACLITAXEL, PACLITAXEL, CAPECITABINE, TRASTUZUMAB, |
||||
| 366 | 25081160 |
CN |
65 | 2 |
Myelosuppression, Gastroenteritis, |
||||
PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, |
||||
| 367 | 25077464 |
CN |
66 | 1 |
Myelosuppression, Platelet count decreased, Neutrophil count decreased, White blood cell count decreased, Anaemia, |
||||
VENETOCLAX, VENETOCLAX, CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE, WATER, STERILE WATER, STERILE WATER FOR INJECTION, |
||||
| 368 | 25078090 |
CN |
61 | 1 |
Myelosuppression, |
||||
CARFILZOMIB, |
||||
| 369 | 25078124 |
ES |
7 | 1 |
Anaemia, Thrombocytopenia, Hepatotoxicity, Drug interaction, Drug ineffective, Drug level increased, Myelosuppression, Malignant neoplasm progression, |
||||
LINEZOLID, LINEZOLID, LINEZOLID, MIRTAZAPINE, PACLITAXEL, VINORELBINE, CARBOPLATIN, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, TRIMETHOPRIM, LINEZOLID, LINEZOLID, LINEZOLID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, APIXABAN, ALPRAZOLAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFTRIAXONE, CEFTRIAXONE SODIUM, AMIKACIN, |
||||
| 370 | 25079095 |
GB |
46 | 1 |
Neutropenia, Myelosuppression, Osteonecrosis, Osteoarthritis, Fear of injection, Arthralgia, |
||||
CABOTEGRAVIR SODIUM, |
||||
| 371 | 25079249 |
CN |
54 | 2 |
Myelosuppression, |
||||
PEMBROLIZUMAB, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 372 | 25079307 |
CN |
70 | |
Myelosuppression, |
||||
CAPECITABINE, CAPECITABINE, |
||||
| 373 | 25079391 |
CN |
54 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 374 | 25079447 |
CN |
4 | 2 |
Myelosuppression, C-reactive protein increased, |
||||
CYTARABINE, CYTARABINE, |
||||
| 375 | 25079500 |
CN |
67 | 2 |
Myelosuppression, Off label use, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, RIFABUTIN, ETHAMBUTOL HYDROCHLORIDE, |
||||
| 376 | 25079636 |
CN |
41 | 2 |
Myelosuppression, |
||||
| 377 | 25080107 |
JP |
3 | 2 |
Splenomegaly, BK virus infection, Myelosuppression, Cystitis haemorrhagic, |
||||
AZACITIDINE, CYTARABINE, ETOPOSIDE, |
||||
| 378 | 25080238 |
JP |
74 | 2 |
Dermatitis psoriasiform, Blood corticotrophin increased, Hypokalaemia, Hypomagnesaemia, Myelosuppression, Hypocalcaemia, Malignant neoplasm progression, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 379 | 25071587 |
CN |
61 | 1 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
| 380 | 25071865 |
CN |
55 | |
Myelosuppression, Gastrointestinal disorder, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, TRASTUZUMAB, |
||||
| 381 | 25071899 |
CN |
77 | |
Myelosuppression, Pyrexia, |
||||
CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, PACLITAXEL, BEVACIZUMAB, |
||||
| 382 | 25071912 |
CN |
71 | |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 383 | 25072364 |
ES |
7 | 1 |
Drug level increased, Myelosuppression, Thrombocytopenia, Drug interaction, |
||||
LINEZOLID, LINEZOLID, MIRTAZAPINE, ALPRAZOLAM, APIXABAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 384 | 25072683 |
CN |
7 | 1 |
Myelosuppression, Off label use, Diarrhoea, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL, FLUOROURACIL, PACLITAXEL, PACLITAXEL, |
||||
| 385 | 25072764 |
CN |
82 | |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 386 | 25072769 |
JP |
||
Myelosuppression, |
||||
OSIMERTINIB, OSIMERTINIB, |
||||
| 387 | 25073043 |
US |
70 | 2 |
Myelosuppression, |
||||
LENALIDOMIDE, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 388 | 25073738 |
CN |
61 | 2 |
Myelosuppression, Haemorrhage subcutaneous, Gingival bleeding, |
||||
CAPECITABINE, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 389 | 25073891 |
CN |
58 | 2 |
Myelosuppression, Off label use, |
||||
AZACITIDINE, AZACITIDINE, AZACITIDINE, AZACITIDINE, AZACITIDINE, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 390 | 25074206 |
CN |
67 | 2 |
Myelosuppression, |
||||
CARBOPLATIN, PACLITAXEL, ATROPINE SULFATE, ATROPINE, SPIRONOLACTONE, |
||||
| 391 | 25074579 |
CN |
60 | 2 |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 392 | 25074604 |
CN |
||
Myelosuppression, Hepatic function abnormal, Diarrhoea, Rash, Pyrexia, Nausea, Vomiting, Palmar-plantar erythrodysaesthesia syndrome, Hypokalaemia, Decreased appetite, Neurotoxicity, Fatigue, Stomatitis, Hypothyroidism, Pneumonitis, |
||||
TRASTUZUMAB, TRASTUZUMAB, CAPECITABINE, CAPECITABINE, OXALIPLATIN, OXALIPLATIN, |
||||
| 393 | 25074747 |
CN |
62 | 2 |
Myelosuppression, |
||||
PEMETREXED, PEMETREXED DISODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 394 | 25075069 |
CN |
58 | 2 |
Myelosuppression, Nausea, Decreased appetite, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 395 | 25075083 |
CN |
46 | |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 396 | 25075109 |
CN |
66 | 1 |
Myelosuppression, Product use in unapproved indication, Pyrexia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 397 | 25075114 |
CN |
67 | |
Myelosuppression, Influenza A virus test positive, Pyrexia, Inflammatory marker increased, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 398 | 25075133 |
CN |
55 | 2 |
Myelosuppression, Product use in unapproved indication, Fatigue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 399 | 25075134 |
CN |
68 | 2 |
Myelosuppression, Product use in unapproved indication, Abdominal pain, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 400 | 25075230 |
CN |
77 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28